Skip to main content
Top
Published in: Current Breast Cancer Reports 2/2019

01-06-2019 | Ultrasound | Local-Regional Evaluation and Therapy (DM Euhus, Section Editor)

Ablative Treatment of Breast Cancer; Are We There Yet?

Author: David R Brenin

Published in: Current Breast Cancer Reports | Issue 2/2019

Login to get access

Abstract

Purpose of Review

Breast cancer treatment has evolved through continuous integration of technological advances and changes in our understanding of tumor biology. Radical mastectomy was the best operation for the technology and beliefs of its time. Advances in technology, the acknowledgement that care is best delivered through a multi-modal approach, and continued investigation have resulted in less disfiguring procedures. Ablative therapy for the treatment of breast cancer is the natural continuation of this trend.

Recent Findings

Data from breast cancer ablation trials utilizing various energy forms have been favorable and have led to the development of ongoing multi-center treat and observe studies.

Summary

This paper examines the current status of cryoablation, laser ablation, and focused ultrasound ablation for the treatment of breast cancers. The advantages and shortcomings of each technique are considered and the challenges to be met in order for ablative therapy to become a mainstream clinical treatment of breast cancer are discussed.
Literature
1.
go back to reference Sabel MS, Nehs MA, Su GK, Lowler KP, Ferrara JLM, Chang AE. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat. 2005;90:97–104.CrossRef Sabel MS, Nehs MA, Su GK, Lowler KP, Ferrara JLM, Chang AE. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat. 2005;90:97–104.CrossRef
2.
go back to reference Poplack SP, Levine GM, Henry L, Wells WA, Heinemann FS, Hanna CM, et al. A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection. AJR. 2015;204:1100–8.CrossRef Poplack SP, Levine GM, Henry L, Wells WA, Heinemann FS, Hanna CM, et al. A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection. AJR. 2015;204:1100–8.CrossRef
3.
go back to reference •• Simmons RM, Ballman KV, Cox C, et al. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016;23:2438–45 This study was one of the first, large prospective clinical trials to explore cryoablation to be published. CrossRef •• Simmons RM, Ballman KV, Cox C, et al. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016;23:2438–45 This study was one of the first, large prospective clinical trials to explore cryoablation to be published. CrossRef
4.
go back to reference McArthur HL, Diab A, Page DB, et al. A pilot study of preoperative single-dose Ipilimumab and/or Cryoablation in women with early-stage breast Cancer with comprehensive immune profiling. Clin Cancer Res. 2016;22:5729–37.CrossRef McArthur HL, Diab A, Page DB, et al. A pilot study of preoperative single-dose Ipilimumab and/or Cryoablation in women with early-stage breast Cancer with comprehensive immune profiling. Clin Cancer Res. 2016;22:5729–37.CrossRef
5.
go back to reference Dowlatshahi K, Francescatti DS, Bloom KJ. Laser therapy for small breast cancers. Am J Surg. 2002;184:359–63.CrossRef Dowlatshahi K, Francescatti DS, Bloom KJ. Laser therapy for small breast cancers. Am J Surg. 2002;184:359–63.CrossRef
6.
go back to reference Harms SE. MR-guided minimally invasive procedures. Magn Reson Imaging Clin N Am. 2001;9:381–92.PubMed Harms SE. MR-guided minimally invasive procedures. Magn Reson Imaging Clin N Am. 2001;9:381–92.PubMed
7.
8.
go back to reference •• Schwartzberg B, Lewin J, Abdelatif O, et al. Phase 2 open-label trial investigating percutaneous laser ablation for treatment of early-stage breast Cancer: MRI, pathology, and outcome correlations. Ann Surg Oncol. 2018;25(10):2958–64 This study is the first, large well designed, prospective clinical trials to explore laser ablation to be published. CrossRef •• Schwartzberg B, Lewin J, Abdelatif O, et al. Phase 2 open-label trial investigating percutaneous laser ablation for treatment of early-stage breast Cancer: MRI, pathology, and outcome correlations. Ann Surg Oncol. 2018;25(10):2958–64 This study is the first, large well designed, prospective clinical trials to explore laser ablation to be published. CrossRef
9.
go back to reference Dowlatshahi K, Francescatti D, Bloom K. Laser therapy for small breast cancers. Am J Surg. 2002;184:359–63.CrossRef Dowlatshahi K, Francescatti D, Bloom K. Laser therapy for small breast cancers. Am J Surg. 2002;184:359–63.CrossRef
10.
go back to reference van Esser S, Stapper G, van Diest PJ, van den Bosch MAAJ, Klaessens JHGM, Mali WPTM, et al. Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol. 2009;16:2259–63.CrossRef van Esser S, Stapper G, van Diest PJ, van den Bosch MAAJ, Klaessens JHGM, Mali WPTM, et al. Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol. 2009;16:2259–63.CrossRef
11.
go back to reference Hill CR, ter Haar GR. High intensity focused ultrasound: potential for cancer treatment. Br J Radiol. 1995;68:1296–303.CrossRef Hill CR, ter Haar GR. High intensity focused ultrasound: potential for cancer treatment. Br J Radiol. 1995;68:1296–303.CrossRef
12.
go back to reference Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099–106.CrossRef Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099–106.CrossRef
13.
go back to reference Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg. 2006;203:54–63.CrossRef Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg. 2006;203:54–63.CrossRef
14.
go back to reference Gambos EC, Kacher DF, Furusawa H, Namba K. Breast focused ultrasound surgery with magnetic resonance guidance. Top Magn Reson Imaging. 2006;17:181–8.CrossRef Gambos EC, Kacher DF, Furusawa H, Namba K. Breast focused ultrasound surgery with magnetic resonance guidance. Top Magn Reson Imaging. 2006;17:181–8.CrossRef
15.
go back to reference Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness-initial experience. Radiology. 2003;227:849–55.CrossRef Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness-initial experience. Radiology. 2003;227:849–55.CrossRef
16.
go back to reference Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, et al. The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer. 2007;14:55–8.CrossRef Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, et al. The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer. 2007;14:55–8.CrossRef
17.
go back to reference Furusawa H. Treatment of Breast Cancer. Plenary session presented at the second international symposium on MR-guided focused ultrasound, October 2010, Washington, DC. Furusawa H. Treatment of Breast Cancer. Plenary session presented at the second international symposium on MR-guided focused ultrasound, October 2010, Washington, DC.
18.
go back to reference Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo Marincola B, Brachetti G, et al. MR-guided high-intensity focused ultrasound: current status of an emerging technology. Cardiovasc Intervent Radiol. 2013;36:1190–203.CrossRef Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo Marincola B, Brachetti G, et al. MR-guided high-intensity focused ultrasound: current status of an emerging technology. Cardiovasc Intervent Radiol. 2013;36:1190–203.CrossRef
19.
go back to reference Wu F, Wang Z-B, Cao Y-D, Chen W-Z, Bai J, Zou J-Z, et al. A randomized clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localized breast cancer. Brit J Cancer. 2003;89:2227–33.CrossRef Wu F, Wang Z-B, Cao Y-D, Chen W-Z, Bai J, Zou J-Z, et al. A randomized clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localized breast cancer. Brit J Cancer. 2003;89:2227–33.CrossRef
20.
go back to reference Wu F, Wang Z-B, Zhu H, Chen W-Z, Zou J-Z, Bai J, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat. 2005;92:51–60.CrossRef Wu F, Wang Z-B, Zhu H, Chen W-Z, Zou J-Z, Bai J, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat. 2005;92:51–60.CrossRef
21.
go back to reference Wu F, Wang Z-B, Cao Y-D, Zhu X-Q, Zhy H, Chen W-Z, et al. Wide local ablation of localized breast cancer using high intensity focused ultrasound. J Surg Oncol. 2007;96:130–6.CrossRef Wu F, Wang Z-B, Cao Y-D, Zhu X-Q, Zhy H, Chen W-Z, et al. Wide local ablation of localized breast cancer using high intensity focused ultrasound. J Surg Oncol. 2007;96:130–6.CrossRef
23.
go back to reference • Merckel LG, Knuttel FM, Deckers R, van Dalen T, Schubert G, Peters NHGM, et al. First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation. Eur Radiol. 2016;26:4037–46 This important study describes the use of the first breast specific focused ultrasound ablation device.CrossRef • Merckel LG, Knuttel FM, Deckers R, van Dalen T, Schubert G, Peters NHGM, et al. First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation. Eur Radiol. 2016;26:4037–46 This important study describes the use of the first breast specific focused ultrasound ablation device.CrossRef
25.
Metadata
Title
Ablative Treatment of Breast Cancer; Are We There Yet?
Author
David R Brenin
Publication date
01-06-2019
Publisher
Springer US
Published in
Current Breast Cancer Reports / Issue 2/2019
Print ISSN: 1943-4588
Electronic ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-019-0307-1

Other articles of this Issue 2/2019

Current Breast Cancer Reports 2/2019 Go to the issue

Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Management of B3 Lesions—Practical Issues

Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Interval Cancers and Duty of Candour, a UK Perspective

Local-Regional Evaluation and Therapy (DM Euhus, Section Editor)

Role of Liquid Biopsy in Clinical Decision-Making for Breast Cancer

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine